Tags : Develop of Potential

Biotech

Eli Lilly Signs an Exclusive Agreement with Precision BioSciences on

Shots: Precision to receive $100M upfront, $35M as an equity investment and will receive $420M as milestones/ product along with royalties on sales of licensed products emerges from the collaboration, making a total deal value ~$2.7B Precision will lead to pre-clinical research and IND-enabling activities while Lilly will lead clinical development and commercialization and have […]Read More

Biotech

Eli Lilly Signs an Exclusive Agreement with Precision BioSciences on

Shots: Precision to receive $100M upfront, $35M as an equity investment and will receive $420M as milestones/ product along with royalties on sales of licensed products emerges from the collaboration, making a total deal value ~$2.7B Precision will lead to pre-clinical research and IND-enabling activities while Lilly will lead clinical development and commercialization and have […]Read More